Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000235503 | SCV000294106 | uncertain significance | not provided | 2018-07-23 | criteria provided, single submitter | clinical testing | This variant is denoted BRCA1 c.5571G>T at the cDNA level, p.Gln1857His (Q1857H) at the protein level, and results in the change of a Glutamine to a Histidine (CAG>CAT). Using alternate nomenclature, this variant would be defined as BRCA1 5690G>T. This variant has not, to our knowledge, been published in the literature as a pathogenic or benign germline variant. BRCA1 Gln1857His was not observed in large population cohorts (Lek 2016). This variant is located in a region known to interact with multiple proteins (Paul 2014). In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function. Based on currently available evidence, it is unclear whether BRCA1 Gln1857His is a pathogenic or benign variant. We consider it to be a variant of uncertain significance. |
Color | RCV000773214 | SCV000906806 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-10-30 | criteria provided, single submitter | clinical testing |